U.S. Facial Injectable Market Size, Share & Trends Analysis Report By Product (Botulinum Toxin Type A, HA), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-4-68040-284-1
- Number of Report Pages: 70
- Format: PDF, Horizon Databook
- Historical Range: 2018 - 2022
- Forecast Period: 2024 - 2030
- Industry: Healthcare
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.3. Competitive Insights
Chapter 3. U.S. Facial Injectable Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing geriatric population
3.2.1.2. Rising awareness of aesthetic procedures
3.2.1.3. Increasing availability of innovative products
3.2.1.4. Rise in the number of aesthetic procedures performed
3.2.2. Market restraint analysis
3.2.2.1. Threat of side effects
3.3. U.S. Facial Injectable Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. U.S. Facial Injectable Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Facial Injectable Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Collagen & PMMA microspheres
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Botulinum toxin type A
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. HA
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. CaHA
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. PLLA
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Facial Injectable Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Facial Injectable Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Facial line correction
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Lip augmentation
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Face lift
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Acne scar treatment
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Lipoatrophy treatment
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Facial Injectable Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Facial Injectable Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. MedSpa
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Dermatology clinics
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Hospitals
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Facial Injectable Market: Region Estimates & Trend Analysis
7.1. Regional Market Share, 2023 & 2030
7.2. U.S. Facial Injectable Market by Region Outlook
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.3.1. West
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.3.2. Midwest
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Northeast
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.4. Southwest
7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.5. Southeast
7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. AbbVie, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. REVANCE AESTHETICS
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Merz North America, Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Galderma Laboratories, L.P.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Suneva Medical Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Cytophil, Inc
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Prollenium Medical Technologies.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. facial injectable market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. facial injectable market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. facial injectable market, by region, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. facial injectable market: market outlook
Fig. 9 U.S. facial injectable competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. facial injectable market driver impact
Fig. 14 U.S. facial injectable market restraint impact
Fig. 15 U.S. facial injectable market: Product movement analysis
Fig. 16 U.S. facial injectable market: Product outlook and key takeaways
Fig. 17 Collagen & PMMA microspheres market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Botulinum toxin type A market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 HA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 CaHA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 PLLA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 U.S. facial injectable market: Application movement Analysis
Fig. 24 U.S. facial injectable market: Application outlook and key takeaways
Fig. 25 Facial line correction market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Lip augmentation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Face lift market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Acne scar treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Lipoatrophy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 U.S. facial injectable market: End-use movement analysis
Fig. 32 U.S. facial injectable market: End-use outlook and key takeaways
Fig. 33 MedSpa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Dermatology clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 U.S. facial injectable market: Regional movement analysis
Fig. 37 U.S. facial injectable market: Regional outlook and key takeaways
Fig. 38 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
